HomeStock ScreenerSenores PharmaceuticalsShareholding Pattern

Senores Pharmaceuticals Shareholding Pattern

As of Jun 2026, Senores Pharmaceuticals (SENORES) promoter holding 45.82%, FII 6.62%, DII 9.77%, public 29.25%, total shareholders 36,498. Browse SENORES annual financials for revenue, profit, balance sheet and cash flow data.

Promoter Holding 45.82%
FII Holding 6.62%
DII Holding 9.77%
Public Holding 29.25%
Total Shareholders 36,498
As of Jun 2026

SENORES Recent Shareholding Changes — Promoter, FII & DII

Senores Pharmaceuticals promoter, FII and DII holding change from Mar 2026 to Jun 2026, FII +2.98%, DII +0.16%. Explore Senores Pharmaceuticals intrinsic worth to estimate fundamental worth using multiple valuation models.

Promoter Holding Change
Mar 2026 to Jun 2026
No Change
FII Holding Change
Mar 2026 to Jun 2026
+2.98%
DII Holding Change
Mar 2026 to Jun 2026
+0.16%
Public Holding Change
Mar 2026 to Jun 2026
-2.39%

Senores Pharmaceuticals Quarterly Shareholding Trend — Promoter, FII, DII & Public

SENORES promoter, FII, DII, public and government holding % by quarter — institutional ownership and promoter pledge trends. For live price, key ratios and the full company profile, see Senores Pharmaceuticals screener.

Promoter
FII
DII
Public
Government

SENORES Shareholding Pattern Data — Quarterly History

Senores Pharmaceuticals quarterly promoter, FII, DII, public holding % and total shareholders. Download as Excel or CSV.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Jun 2026 45.82% 6.62% 9.77% 0.00% 29.25% 8.55% 100.01% 36,498
Mar 2026 45.82% 3.64% 9.61% 0.00% 31.64% 9.30% 100.01% 34,126
Dec 2025 45.80% 3.35% 9.31% 0.00% 31.94% 9.59% 99.99% 34,401
Sept 2025 45.80% 4.28% 8.61% 0.00% 31.09% 10.22% 100.00% 34,917
Jun 2025 45.78% 3.67% 9.51% 0.00% 31.44% 9.60% 100.00% 36,389
Mar 2025 45.77% 4.17% 9.65% 0.00% 31.43% 8.97% 99.99% 37,653
Dec 2024 45.76% 4.25% 11.78% 0.00% 28.71% 9.49% 99.99% 43,707
Sept 2024 45.76% 5.51% 18.61% 0.00% 27.88% 2.23% 99.99% 43,707
Jul 2024 66.66% 0.00% 0.00% 0.00% 0.00% 33.34% 100.00% 177
Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Jun 2026 45.82% 6.62% 9.77% 0.00% 29.25% 8.55% 100.01% 36,498
Mar 2026 45.82% 3.64% 9.61% 0.00% 31.64% 9.30% 100.01% 34,126
Dec 2025 45.80% 3.35% 9.31% 0.00% 31.94% 9.59% 99.99% 34,401
Sept 2025 45.80% 4.28% 8.61% 0.00% 31.09% 10.22% 100.00% 34,917
Jun 2025 45.78% 3.67% 9.51% 0.00% 31.44% 9.60% 100.00% 36,389
Mar 2025 45.77% 4.17% 9.65% 0.00% 31.43% 8.97% 99.99% 37,653
Dec 2024 45.76% 4.25% 11.78% 0.00% 28.71% 9.49% 99.99% 43,707
Sept 2024 45.76% 5.51% 18.61% 0.00% 27.88% 2.23% 99.99% 43,707
Jul 2024 66.66% 0.00% 0.00% 0.00% 0.00% 33.34% 100.00% 177
Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 45.82% 3.64% 9.61% 0.00% 31.64% 9.30% 100.01% 34,126
Dec 2025 45.80% 3.35% 9.31% 0.00% 31.94% 9.59% 99.99% 34,401
Dec 2024 45.76% 4.25% 11.78% 0.00% 28.71% 9.49% 99.99% 43,707